“…They combine several advantageous features, including a good safety profile, stable long-term gene expression in several tissues, the ability to transduce dividing and nondividing cells, and physicochemical stability (11,66). AAV vectors show generally a low innate immunity, as well as low efficiency to transduce professional antigen-presenting cells (87), although recent studies warrant a more differentiated view of the immune response to AAV-mediated gene transfer (8,22,23,26,29,32,33,37,50,65,84,88). Humoral immune responses are generated and memory CD8 ϩ T-cell responses have been observed in clinical trials (36,40,58).…”